The Pain Suppressive Effect of Alternative Spinal Cord Stimulation Frequencies

NCT02112474 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-11-30

No results posted yet for this study

Summary

Electrical stimulation of the spinal cord (Spinal Cord Stimulation or SCS) for pain relief has been used for decades. It is used most commonly in patients with chronic neuropathic leg pain, after spinal surgery. Conventional neurostimulation is applied in frequencies of 30 to 60 Hertz (Hz) and perceptible paraesthesias are felt. Stimulation using higher frequencies with sub perception paraesthesias has recently challenged the conventional form of neurostimulation.The high frequency stimulation appears to show better pain relief for both back and limb pain in comparison to low frequency SCS, and may also to be effective in some subjects who did not respond to low frequency SCS.

Conditions

  • Failed Back Surgery Syndrome
  • Neuropathic Pain

Interventions

DEVICE

Spinal Cord Stimulation

Crossover design whereby subjects will undergo Spinal Cord Stimulation in two arms: low frequency stimulation and high frequency stimulation

DEVICE

Group 1

9 days of spinal cord stimulation at 30 Hertz and perceptible paraesthesias

DEVICE

Group 2

9 days of spinal cord stimulation with 1000 Hertz and sub-perception paraesthesias

Sponsors & Collaborators

  • Diakonessenhuis, Utrecht

    collaborator OTHER
  • Rijnstate Hospital

    collaborator OTHER
  • Alrijne Hospital

    collaborator OTHER
  • Noordwest Ziekenhuisgroep

    collaborator OTHER
  • Jennifer Breel

    lead OTHER

Principal Investigators

  • Markus W Hollmann, MD, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Frank Wille, MD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Jennifer S Breel, MPA,MSc. · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-13
Primary Completion
2017-11-17
Completion
2018-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02112474 on ClinicalTrials.gov